Biology:mIRN21

From HandWiki
Revision as of 23:44, 10 February 2024 by StanislovAI (talk | contribs) (change)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Short description: Non-coding RNA in the species Homo sapiens


A representation of the 3D structure of the protein myoglobin showing turquoise α-helices.
Generic protein structure example

microRNA 21 also known as hsa-mir-21 or miRNA21 is a mammalian microRNA that is encoded by the MIR21 gene.[1]

MIRN21 was one of the first mammalian microRNAs identified. The mature miR-21 sequence is strongly conserved throughout evolution. The human microRNA-21 gene is located on plus strand of chromosome 17q23.2 (55273409–55273480) within a coding gene TMEM49 (also called vacuole membrane protein). Despite being located in intronic regions of a coding gene in the direction of transcription, it has its own promoter regions and forms a ~3433-nt long primary transcript of miR-21 (known as pri-miR-21) which is independently transcribed. The stem–loop precursor of miR-21(pre-miR-21) resides between nucleotides 2445 and 2516 of pri-miR-21.

Mature miR-21

Pri-miR-21 is cut by the endonuclease Drosha in the nucleus to produce pre-miR-21, which is exported into the cytosol. This pre-miR-21 is then cut into a short RNA duplex by Dicer in the cytosol. Although abundance of both strands is equal by transcription, only one strand (miR-21) is selected for processing as mature microRNA based on the thermodynamic stability of each end of the duplex, while the other strand (designated with an asterisk; miR-21*) is generally degraded. Mature microRNA is then loaded into microRNA ribonucleoprotein complex RISC (RNA-induced silencing complex) and guided to target mRNAs with near perfect complementarily at 3'UTR.

Targets

A number of targets for microRNA-21 have been experimentally validated and most of them are tumor suppressors, Notable targets include:


Clinical significance

Cancer

miR-21 is one of the most frequently upregulated miRNAs in solid tumours, and its high levels were first described in B cell lymphomas. Overall, miR-21 is considered to be a typical 'onco-miR', which acts by inhibiting the expression of phosphatases, which limit the activity of signalling pathways such as AKT and MAPK. As most of the targets of miR-21 are tumor suppressors, miR-21 is associated with a wide variety of cancers including that of breast,[18] ovaries,[19] cervix,[20] colon,[10] lung,[21] liver,[11] brain,[22] esophagus,[23] prostate,[21] pancreas,[21] and thyroid.[24] A 2014 meta-analysis of 36 studies evaluated circulating miR-21 as a biomarker of various carcinomas, finding it has potential as a tool for early diagnosis.[25] miR-21 expression was associated with survival in 53 triple negative breast cancer patients.[26] miR-21 can also be detected in human faeces from colorectal cancer patients.[27] Additionally, it has been demonstrated as an independent prognostic factor in patients with pancreatic neuroendocrine neoplasms.[28]

Cardiac disease

miR-21 has been shown to play important role in development of heart disease. It is one of the microRNAs whose expression is increased in failing murine and human hearts.[16][29] Further, inhibition of microRNAs in mice using chemically modified and cholesterol-conjugated miRNA inhibitors (antagomirs) was shown to inhibit interstitial fibrosis and improve cardiac function in a pressure- overload cardiac disease mice model.[16] Surprisingly, miR-21 global knock-out mice did not show any overt phenotype when compared with wild type mice with respect to cardiac stress response. Similarly, short (8-nt) oligonucleotides designed to inhibit miR-21 could not inhibit cardiac hypertrophy or fibrosis.[30] In another study with a mouse model of acute myocardial infarction, miR-21 expression was found to be significantly lower in infarcted areas and overexpression of miR-21 in those mice via adenovirus-mediated gene transfer decreased myocardial infarct size.[31] miR-21 has been hypothesized to be an intermediary in the effects of air pollution that lead to endothelial dysfunction and eventually to cardiac disease. Expression of miR-21 is negatively associated with exposure to PM10 air pollution and may mediate its effect on small blood vessels.[32]

References

  1. "Identification of novel genes coding for small expressed RNAs". Science 294 (5543): 853–8. October 2001. doi:10.1126/science.1064921. PMID 11679670. Bibcode2001Sci...294..853L. 
  2. "Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma". Cell Research 19 (7): 828–37. July 2009. doi:10.1038/cr.2009.72. PMID 19546886. 
  3. "Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells". Nucleic Acids Research 37 (8): 2584–95. May 2009. doi:10.1093/nar/gkp117. PMID 19264808. 
  4. "miR-21 downregulates the tumor suppressor P12 CDK2AP1 and stimulates cell proliferation and invasion". Journal of Cellular Biochemistry 112 (3): 872–80. March 2011. doi:10.1002/jcb.22995. PMID 21328460. 
  5. 5.0 5.1 5.2 "MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells". Cancer Research 68 (19): 8164–72. October 2008. doi:10.1158/0008-5472.CAN-08-1305. PMID 18829576. 
  6. "MicroRNA-21 is up-regulated in allergic airway inflammation and regulates IL-12p35 expression". Journal of Immunology 182 (8): 4994–5002. April 2009. doi:10.4049/jimmunol.0803560. PMID 19342679. 
  7. "MicroRNA profiling identifies miR-34a and miR-21 and their target genes JAG1 and WNT1 in the coordinate regulation of dendritic cell differentiation". Blood 114 (2): 404–14. July 2009. doi:10.1182/blood-2008-09-179150. PMID 19398721. 
  8. "MicroRNA-21 dysregulates the expression of MEF2C in neurons in monkey and human SIV/HIV neurological disease". Cell Death & Disease 1 (9): e77. September 2010. doi:10.1038/cddis.2010.56. PMID 21170291. 
  9. "MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2)". Proceedings of the National Academy of Sciences of the United States of America 107 (49): 21098–103. December 2010. doi:10.1073/pnas.1015541107. PMID 21078976. Bibcode2010PNAS..10721098V. 
  10. 10.0 10.1 "MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer". Oncogene 27 (15): 2128–36. April 2008. doi:10.1038/sj.onc.1210856. PMID 17968323. 
  11. 11.0 11.1 "MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer". Gastroenterology 133 (2): 647–58. August 2007. doi:10.1053/j.gastro.2007.05.022. PMID 17681183. 
  12. "MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators". Molecular and Cellular Biology 28 (17): 5369–80. September 2008. doi:10.1128/MCB.00479-08. PMID 18591254. 
  13. "MicroRNA-21 exhibits antiangiogenic function by targeting RhoB expression in endothelial cells". PLOS ONE 6 (2): e16979. February 2011. doi:10.1371/journal.pone.0016979. PMID 21347332. Bibcode2011PLoSO...616979S. 
  14. "MicroRNA-21 targets tumor suppressor genes ANP32A and SMARCA4". Oncogene 30 (26): 2975–85. June 2011. doi:10.1038/onc.2011.15. PMID 21317927. 
  15. "MiR-21 regulates adipogenic differentiation through the modulation of TGF-beta signaling in mesenchymal stem cells derived from human adipose tissue". Stem Cells 27 (12): 3093–102. December 2009. doi:10.1002/stem.235. PMID 19816956. 
  16. 16.0 16.1 16.2 "MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts". Nature 456 (7224): 980–4. December 2008. doi:10.1038/nature07511. PMID 19043405. Bibcode2008Natur.456..980T. 
  17. "MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths". Molecular Biology of the Cell 19 (8): 3272–82. August 2008. doi:10.1091/mbc.E08-02-0159. PMID 18508928. 
  18. "MicroRNA gene expression deregulation in human breast cancer". Cancer Research 65 (16): 7065–70. August 2005. doi:10.1158/0008-5472.CAN-05-1783. PMID 16103053. 
  19. "MicroRNA signatures in human ovarian cancer". Cancer Research 67 (18): 8699–707. September 2007. doi:10.1158/0008-5472.CAN-07-1936. PMID 17875710. 
  20. "Patterns of known and novel small RNAs in human cervical cancer". Cancer Research 67 (13): 6031–43. July 2007. doi:10.1158/0008-5472.CAN-06-0561. PMID 17616659. 
  21. 21.0 21.1 21.2 "A microRNA expression signature of human solid tumors defines cancer gene targets". Proceedings of the National Academy of Sciences of the United States of America 103 (7): 2257–61. February 2006. doi:10.1073/pnas.0510565103. PMID 16461460. Bibcode2006PNAS..103.2257V. 
  22. "MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells". Cancer Research 65 (14): 6029–33. July 2005. doi:10.1158/0008-5472.CAN-05-0137. PMID 16024602. 
  23. "Prognostic significance of differentially expressed miRNAs in esophageal cancer". International Journal of Cancer 128 (1): 132–43. January 2011. doi:10.1002/ijc.25330. PMID 20309880. 
  24. "Differential expression of miRNAs in papillary thyroid carcinoma compared to multinodular goiter using formalin fixed paraffin embedded tissues". Endocrine Pathology 18 (3): 163–73. 2007. doi:10.1007/s12022-007-0023-7. PMID 18058265. 
  25. "Circulating microRNA-21 as a biomarker for the detection of various carcinomas: an updated meta-analysis based on 36 studies". Tumour Biology 36 (3): 1973–81. March 2015. doi:10.1007/s13277-014-2803-2. PMID 25527152. 
  26. "miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients". Breast Cancer Research and Treatment 160 (3): 439–446. December 2016. doi:10.1007/s10549-016-4013-7. PMID 27744485. 
  27. "Faecal microRNAs as a non-invasive tool in the diagnosis of colonic adenomas and colorectal cancer: A meta-analysis". Scientific Reports 9 (1): 9491. July 2019. doi:10.1038/s41598-019-45570-9. PMID 31263200. Bibcode2019NatSR...9.9491Y. 
  28. "Prognostic relevance of proliferation-related miRNAs in pancreatic neuroendocrine neoplasms". European Journal of Endocrinology 179 (4): EJE–18–0305. July 2018. doi:10.1530/EJE-18-0305. PMID 30006373. http://www.eje-online.org/content/early/2018/07/13/EJE-18-0305. 
  29. "MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue". Cardiovascular Research 82 (1): 21–9. April 2009. doi:10.1093/cvr/cvp015. PMID 19147652. 
  30. "Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice". The Journal of Clinical Investigation 120 (11): 3912–6. November 2010. doi:10.1172/JCI43604. PMID 20978354. 
  31. "MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction". The Journal of Biological Chemistry 284 (43): 29514–25. October 2009. doi:10.1074/jbc.M109.027896. PMID 19706597. 
  32. "miRNA expression profiles and retinal blood vessel calibers are associated with short-term particulate matter air pollution exposure". Environmental Research 147: 24–31. May 2016. doi:10.1016/j.envres.2016.01.027. PMID 26836502. Bibcode2016ER....147...24L. 

Further reading

  • "Role for MicroRNA-21 in atrial profibrillatory fibrotic remodeling associated with experimental postinfarction heart failure". Circulation: Arrhythmia and Electrophysiology 5 (5): 1027–35. October 2012. doi:10.1161/CIRCEP.112.973214. PMID 22923342. 
  • "miR-21 induces cell cycle at S phase and modulates cell proliferation by down-regulating hMSH2 in lung cancer". Journal of Cancer Research and Clinical Oncology 138 (10): 1781–8. October 2012. doi:10.1007/s00432-012-1287-y. PMID 22806311. 

External links